Advocacy intelligence hub — real-time data for patient organizations
Assistance Publique - Hôpitaux de Paris — PHASE3
Riphah International University — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Azithromycin
(AZITHROMYCIN)Orphan drugstandardPreferred Pharmaceuticals Inc.
Francisco H Unda, PT, MSc
Universidad Europea de Madrid
Rabiya Noor, PhD, MD
Riphah International University
📍 NOTTINGHAM, MD
Frédéric Schils, MD
CHC Liège, Belgium
John Yeh, MD
Royal London Hospital, UK
Patrick Guérin, MD
University Hospital, Bordeaux
Tim L Uhl, PhD, PhD ATC PT
University of Kentucky
📍 LEXINGTON, KY